ACM
RMD icon

Aster Capital Management’s ResMed RMD Stock Holding History

Aster Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-802
Closed -$193K – 1254
2025
Q4 		$193K Sell
802
-1,450
-64% -$371K 0.08% 229
2025
Q3 		$616K Buy
+2,252
New +$615K 0.31% 74
2025
Q2 		– Sell
-744
Closed -$174K – 1492
2025
Q1 		$174K Buy
+744
New +$174K 0.03% 516

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aster Capital Management's RMD Position: Q1 2026 in Review

Aster Capital Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 802 shares — an estimated $193K sold.

Aster Capital Management first reported a position in RMD in Q1 2025 and held it in 3 quarters. The position peaked at $616K in Q3 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Aster Capital Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 802 ResMed shares in Q1 2026, an estimated $193K.
  • Aster Capital Management first reported a position in ResMed in Q1 2025 and held it in 3 quarters.
  • Aster Capital Management's ResMed position peaked at $616K in Q3 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.